Cantarini, MV, Painter, CJ, Hughes, AM (2004). Effect of oral linezolid on the pressor response to intravenous tyramine. British Journal of Clinical Pharmacology 58, 470–475.
Falagas, ME, Vardakas, KZ (2008). Benefit-risk assessment of linezolid for serious gram-positive bacterial infections. Drug Safety: An International Journal of Medical Toxicology and Drug Experience 31, 753–768.
Lawrence, KR, Adra, M, Gillman, PK (2006). Serotonin toxicity associated with the use of linezolid: a review of postmarketing data. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 42, 1578–1583.
Pfizer Healthcare Ireland (2012). Zyvox: summary of product characteristics (http://www.medicines.ie). Accessed 21 May 2012.
Quinn, DK, Stern, TA (2009). Linezolid and serotonin syndrome. Primary Care Companion to the Journal of Clinical Psychiatry 11, 353–356.
Taylor, JJ, Wilson, JW, Estes, LL (2006). Linezolid and serotonergic drug interactions: a retrospective survey. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 43, 180–187.
Vardakas, KZ, Ntziora, F, Falagas, ME (2007). Linezolid: effectiveness and safety for approved and off-label indications. Expert Opinion on Pharmacotherapy 8, 2381–2400.